The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
CD244 (Cluster of Differentiation 244) is a human protein encoded by the CD244gene.[1] It is also known as Natural Killer Cell Receptor 2B4[2]
This gene encodes a cell surface receptor expressed on natural killer cells (NK cells) (and some T cells) mediating non-major histocompatibility complex (MHC) restricted killing. The interaction between NK-cell and target cells via this receptor is thought to modulate NK-cell cytolytic activity. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[3]
CD244 can also be expressed on non-lymphocytes such as eosinophils, mast cells and dendritic cells.[4]
Vaidya SV, Mathew PA (2006). "Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells". Immunol. Lett. 105 (2): 180–4. doi:10.1016/j.imlet.2006.02.006. PMID16621032.
Latchman Y, McKay PF, Reiser H (1998). "Identification of the 2B4 molecule as a counter-receptor for CD48". J. Immunol. 161 (11): 5809–12. PMID9834056.
Tangye SG, Lazetic S, Woollatt E, et al. (1999). "Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP". J. Immunol. 162 (12): 6981–5. PMID10358138.
Boles KS, Nakajima H, Colonna M, et al. (1999). "Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4". Tissue Antigens. 54 (1): 27–34. doi:10.1034/j.1399-0039.1999.540103.x. PMID10458320.
Kumaresan PR, Mathew PA (2000). "Structure of the human natural killer cell receptor 2B4 gene and identification of a novel alternative transcript". Immunogenetics. 51 (11): 987–92. doi:10.1007/s002510000237. PMID11003394.
Watzl C, Stebbins CC, Long EO (2000). "NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244)". J. Immunol. 165 (7): 3545–8. doi:10.4049/jimmunol.165.7.3545. PMID11034353.
Chuang SS, Pham HT, Kumaresan PR, Mathew PA (2001). "A prominent role for activator protein-1 in the transcription of the human 2B4 (CD244) gene in NK cells". J. Immunol. 166 (10): 6188–95. doi:10.4049/jimmunol.166.10.6188. PMID11342640.
Morra M, Simarro-Grande M, Martin M, et al. (2001). "Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients". J. Biol. Chem. 276 (39): 36809–16. doi:10.1074/jbc.M101305200. PMID11477068.
Speiser DE, Colonna M, Ayyoub M, et al. (2002). "The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells". J. Immunol. 167 (11): 6165–70. doi:10.4049/jimmunol.167.11.6165. PMID11714776.
Chuang SS, Kumaresan PR, Mathew PA (2002). "2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways". J. Immunol. 167 (11): 6210–6. doi:10.4049/jimmunol.167.11.6210. PMID11714782.
Bottino C, Parolini S, Biassoni R, et al. (2002). X-linked lymphoproliferative disease: the dark side of 2b4 function. Adv. Exp. Med. Biol. Advances in Experimental Medicine and Biology. 495. pp. 63–7. doi:10.1007/978-1-4615-0685-0_9. ISBN978-1-4613-5194-8. PMID11774610.
Aoukaty A, Tan R (2002). "Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase". J. Biol. Chem. 277 (15): 13331–7. doi:10.1074/jbc.M112029200. PMID11815622.
Assarsson E, Kambayshi T, Persson C, et al. (2005). "2B4 co-stimulation: NK cells and their control of adaptive immune responses". Mol. Immunol. 42 (4): 419–23. doi:10.1016/j.molimm.2004.07.021. PMID15607793.